References
- Barabutis N. Unfolded protein response in the COVID-19 context. Aging Health Res. 2021;1(1):1. doi:https://doi.org/10.1016/j.ahr.2020.100001.
- Linfield DT, Raduka A, Aghapour M, Rezaee F. Airway tight junctions as targets of viral infections. Tissue Barriers. 2021;9(2):1883965. doi:https://doi.org/10.1080/21688370.2021.1883965.
- Gorman E, Millar J, McAuley D, O’Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med. 2021;15(3):301–6. doi:https://doi.org/10.1080/17476348.2021.1848555.
- Joseph BB, Wang Y, Edeen P, Lažetić V, Grant BD, Fay DS. Control of clathrin-mediated endocytosis by NIMA family kinases. PLoS Genet. 2020;16(2):e1008633. doi:https://doi.org/10.1371/journal.pgen.1008633.
- Vasileva E, Citi S. The role of microtubules in the regulation of epithelial junctions. Tissue Barriers. 2018;6(3):1539596. doi:https://doi.org/10.1080/21688370.2018.1539596.
- Lazetic V, Joseph BB, Bernazzani SM, Fay DS. Actin organization and endocytic trafficking are controlled by a network linking NIMA-related kinases to the CDC-42-SID-3/ACK1 pathway. PLoS Genet. 2018;14(4):e1007313. doi:https://doi.org/10.1371/journal.pgen.1007313.
- Lu G, Tian S, Sun Y, Dong J, Wang N, Zeng J, Nie Y, Wu K, Han Y, Feng B, et al. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation. Theranostics. 2021;11(5):2460–2474. doi:https://doi.org/10.7150/thno.53169.
- Chen G, Zhou J, Chen J, Zhu J, Liu S-C, Ding X-F, Zhang Q. VHL regulates NEK1 via both HIF-2α pathway and ubiquitin-proteasome pathway in renal cancer cell. Biochem Biophys Res Commun. 2019;509(3):797–802. doi:https://doi.org/10.1016/j.bbrc.2019.01.001.
- He Y, Zeng MY, Yang D, Motro B, Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530(7590):354–357. doi:https://doi.org/10.1038/nature16959.
- Chen X, Liu G, Yuan Y, Wu G, Wang S, Yuan L. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling. Cell Death Dis. 2019;10(12):906. doi:https://doi.org/10.1038/s41419-019-2157-1.
- Li G, Dong Y, Liu D, Zou Z, Hao G, Gao X, Pan P, Liang G. NEK7 coordinates rapid neuroinflammation after subarachnoid hemorrhage in mice. Front Neurol. 2020;11:551. doi:https://doi.org/10.3389/fneur.2020.00551.
- Uddin MA, Akhter MS, Kubra K-T, Barabutis N. P53 deficiency potentiates LPS-induced acute lung injury in vivo. Curr Res Physiol. 2020;3:30–33. doi:https://doi.org/10.1016/j.crphys.2020.07.001.
- Van De Kooij B, Creixell P, Van Vlimmeren A, Joughin BA, Miller CJ, Haider N, Simpson CD, Linding R, Stambolic V, Turk BE, et al. Comprehensive substrate specificity profiling of the human Nek kinome reveals unexpected signaling outputs. Elife. 2019;8. doi:https://doi.org/10.7554/eLife.44635
- Smith JA, Mayeux PR, Schnellmann RG. Delayed mitogen-activated protein kinase/extracellular signal–regulated kinase inhibition by trametinib attenuates systemic inflammatory responses and multiple organ injury in murine sepsis*. Crit Care Med. 2016;44(8):e711–20. doi:https://doi.org/10.1097/CCM.0000000000001672.
- Barabutis N, Verin A, Catravas JD. Regulation of pulmonary endothelial barrier function by kinases. Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L832–L845. doi:https://doi.org/10.1152/ajplung.00233.2016.
- Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18. doi:https://doi.org/10.1038/s41572-019-0069-0.
- Koval M. Claudin heterogeneity and control of lung tight junctions. Annu Rev Physiol. 2013;75(1):551–567. doi:https://doi.org/10.1146/annurev-physiol-030212-183809.
- Mitchell LA, Overgaard CE, Ward C, Margulies SS, Koval M. Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2011;301(1):L40–9. doi:https://doi.org/10.1152/ajplung.00299.2010.
- Cohen TS, Gray Lawrence G, Margulies SS, Morty RE. Cultured alveolar epithelial cells from septic rats mimic in vivo septic lung. PLoS One. 2010;5(6):e11322. doi:https://doi.org/10.1371/journal.pone.0011322.
- Franqui-Machin R, Hao M, Bai H, Gu Z, Zhan X, Habelhah H, Jethava Y, Qiu L, Frech I, Tricot G, et al. Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. J Clin Invest. 2018;128(7):2877–2893. doi:https://doi.org/10.1172/JCI98765.
- Wu SM, Lin S-L, Lee K-Y, Chuang H-C, Feng P-H, Cheng W-L, Liao C-J, Chi H-C, Lin Y-H, Tsai C-Y, et al. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. Int J Cancer. 2017;140(7):1581–1596. doi:https://doi.org/10.1002/ijc.30559.
- Hong J, Won M, Ro H. The molecular and pathophysiological functions of members of the LNX/PDZRN E3 ubiquitin ligase family. Molecules. 2020;25(24):5938. doi: https://doi.org/10.3390/molecules25245938. PMID: 33333989; PMCID: PMC7765395.
- Donato MD, Fanelli M, Mariani M, Raspaglio G, Pandya D, He S, Fiedler P, Petrillo M, Scambia G, Ferlini C, et al. Nek6 and Hif-1alpha cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer. Am J Cancer Res. 2015;5(6):1862–1877.
- O'Regan L, Barone G, Adib R, Woo CG, Jeong HJ, Richardson EL, et al. EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7. J Cell Sci. 2020;133(9):jcs241505. doi:https://doi.org/10.1242/jcs.241505. PMID: 32184261; PMCID: PMC7240300.
- Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, Hauenstein AV, Wu Z, Núñez G, Mao Y, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570(7761):338–343. doi:https://doi.org/10.1038/s41586-019-1295-z.
- Sun Z, Gong W, Zhang Y, Jia Z. Physiological and pathological roles of mammalian NEK7. Front Physiol. 2020;11:606996. doi:https://doi.org/10.3389/fphys.2020.606996.
- Chen Y, Meng J, Bi F, Li H, Chang C, Ji C, Liu W. NEK7 regulates NLRP3 inflammasome activation and neuroinflammation post-traumatic brain injury. Front Mol Neurosci. 2019;12:202. doi:https://doi.org/10.3389/fnmol.2019.00202.
- Barabutis N. Growth hormone releasing hormone in endothelial barrier function. Trends in Endocrinology & Metabolism. 2021;32(6):338–340. doi:https://doi.org/10.1016/j.tem.2021.03.001.
- Barabutis N. Regulation of lung endothelial permeability by NEK kinases. IUBMB Life. 2020;72(4):801–804. doi:https://doi.org/10.1002/iub.2251.
- Uddin MA, Barabutis N. P53: the endothelium defender. J Cell Biochem. 2019;120(7):10952–10955. doi:https://doi.org/10.1002/jcb.28511.
- Barabutis N, Dimitropoulou C, Gregory B, Catravas JD. Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition. J Cell Mol Med. 2018;22(3):1792–1804. doi:https://doi.org/10.1111/jcmm.13460.
- Uddin MA, Akhter MS, Singh SS, Kubra K-T, Schally AV, Jois S, Barabutis N. GHRH antagonists support lung endothelial barrier function. Tissue Barriers. 2019;7(4):1669989. doi:https://doi.org/10.1080/21688370.2019.1669989.
- Uddin MA, Akhter MS, Kubra K-T, Whitaker KE, Shipley SL, Smith LM, Barabutis N. Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress. Brain Disord. 2021;1:100001. doi:https://doi.org/10.1016/j.dscb.2020.100001.
- Barabutis N, Akhter MS, Uddin MA, Kubra K-T, Schally AV. GHRH antagonists protect against hydrogen peroxide-induced breakdown of brain microvascular endothelium integrity. Horm Metab Res. 2020;52(5):336–339. doi:https://doi.org/10.1055/a-1149-9347.
- Barabutis N. Unfolded protein response: a regulator of the endothelial barrier. Endocrine and Metabolic Science. 2021;3:100092. doi:https://doi.org/10.1016/j.endmts.2021.100092.
- Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther. 2020;5:90.
- Gully CP, Velazquez-Torres G, Shin J-H, Fuentes-Mattei E, Wang E, Carlock C, Chen J, Rothenberg D, Adams HP, Choi HH, et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A. 2012;109(24):E1513–22. doi:https://doi.org/10.1073/pnas.1110287109.
- Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, Verma IM. Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP. Proc Natl Acad Sci U S A. 2009;106(8):2629–2634. doi:https://doi.org/10.1073/pnas.0812256106.
- Barabutis N, Uddin MA, Catravas JD. Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation. Cytokine. 2019;113:427–432. doi:https://doi.org/10.1016/j.cyto.2018.10.020.
- Kubra KT, Uddin MA, Akhter MS, Barabutis N., et al. 2020. P53 is subjected to lipoteichoic acid-induced phosphorylation in the lungs. TH Open.
- Barabutis N. P53 in acute respiratory distress syndrome. Cell Mol Life Sci. 2020;32(6):4725–4727. doi:https://doi.org/10.1007/s00018-020-03629-1.
- Haider N, Dutt P, Van De Kooij B, Ho J, Palomero L, Pujana MA, Yaffe M, Stambolic V. NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity. Oncogene. 2020;39(30):5252–5266. doi:https://doi.org/10.1038/s41388-020-1361-x.
- Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53(1):19–25. doi:https://doi.org/10.1016/j.immuni.2020.06.017.